JP2008530102A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008530102A5 JP2008530102A5 JP2007555195A JP2007555195A JP2008530102A5 JP 2008530102 A5 JP2008530102 A5 JP 2008530102A5 JP 2007555195 A JP2007555195 A JP 2007555195A JP 2007555195 A JP2007555195 A JP 2007555195A JP 2008530102 A5 JP2008530102 A5 JP 2008530102A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- cycloalkyl
- hydrogen
- nitrogen
- aryl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 63
- 229910052739 hydrogen Inorganic materials 0.000 claims description 40
- 239000001257 hydrogen Substances 0.000 claims description 40
- 229910052757 nitrogen Inorganic materials 0.000 claims description 37
- 229910052736 halogen Inorganic materials 0.000 claims description 22
- 125000003545 alkoxy group Chemical group 0.000 claims description 21
- 150000002367 halogens Chemical class 0.000 claims description 14
- 125000003342 alkenyl group Chemical group 0.000 claims description 11
- 150000001875 compounds Chemical class 0.000 claims description 11
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims description 11
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 10
- 229910052799 carbon Inorganic materials 0.000 claims description 10
- 125000000392 cycloalkenyl group Chemical group 0.000 claims description 10
- 125000001475 halogen functional group Chemical group 0.000 claims description 8
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims description 8
- 150000003839 salts Chemical class 0.000 claims description 8
- 125000004429 atom Chemical group 0.000 claims description 6
- 125000006711 (C2-C12) alkynyl group Chemical group 0.000 claims description 3
- 125000004430 oxygen atom Chemical group O* 0.000 claims description 3
- IPWGCHBBVBSTMX-UHFFFAOYSA-N 3-[[5-[1-[4-(4-tert-butylphenyl)-3,5-dimethylphenyl]sulfanyl-2,2-dimethylpropyl]thiophene-2-carbonyl]amino]propanoic acid Chemical compound C=1C(C)=C(C=2C=CC(=CC=2)C(C)(C)C)C(C)=CC=1SC(C(C)(C)C)C1=CC=C(C(=O)NCCC(O)=O)S1 IPWGCHBBVBSTMX-UHFFFAOYSA-N 0.000 claims description 2
- 125000004093 cyano group Chemical group *C#N 0.000 claims 7
- 125000000217 alkyl group Chemical group 0.000 claims 6
- 125000001424 substituent group Chemical group 0.000 claims 4
- -1 - nitro Chemical group 0.000 claims 3
- 125000000304 alkynyl group Chemical group 0.000 claims 1
- 125000000753 cycloalkyl group Chemical group 0.000 claims 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 238000006467 substitution reaction Methods 0.000 claims 1
- 150000002431 hydrogen Chemical class 0.000 description 4
- 125000006701 (C1-C7) alkyl group Chemical group 0.000 description 1
- 125000006272 (C3-C7) cycloalkyl group Chemical group 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US65249205P | 2005-02-11 | 2005-02-11 | |
| US60/652,492 | 2005-02-11 | ||
| PCT/US2006/004461 WO2006086488A2 (en) | 2005-02-11 | 2006-02-09 | Substituted thiophene derivatives as glucagon receptor antagonists, preparation and therapeutic uses |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008530102A JP2008530102A (ja) | 2008-08-07 |
| JP2008530102A5 true JP2008530102A5 (OSRAM) | 2009-03-26 |
| JP4988604B2 JP4988604B2 (ja) | 2012-08-01 |
Family
ID=36694345
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007555195A Expired - Fee Related JP4988604B2 (ja) | 2005-02-11 | 2006-02-09 | グルカゴン受容体アンタゴニストとしての置換チオフェン誘導体、その調製及び治療への使用 |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US8084489B2 (OSRAM) |
| EP (1) | EP1856090B1 (OSRAM) |
| JP (1) | JP4988604B2 (OSRAM) |
| KR (1) | KR20070104409A (OSRAM) |
| CN (1) | CN101115735B (OSRAM) |
| AT (1) | ATE445609T1 (OSRAM) |
| AU (1) | AU2006213894B2 (OSRAM) |
| BR (1) | BRPI0607015A2 (OSRAM) |
| CA (1) | CA2597073C (OSRAM) |
| CR (1) | CR9304A (OSRAM) |
| CY (1) | CY1109624T1 (OSRAM) |
| DE (1) | DE602006009773D1 (OSRAM) |
| DK (1) | DK1856090T3 (OSRAM) |
| EA (1) | EA200701705A1 (OSRAM) |
| ES (1) | ES2332470T3 (OSRAM) |
| IL (1) | IL184932A0 (OSRAM) |
| MA (1) | MA29432B1 (OSRAM) |
| MX (1) | MX2007009661A (OSRAM) |
| NO (1) | NO20074567L (OSRAM) |
| PL (1) | PL1856090T3 (OSRAM) |
| PT (1) | PT1856090E (OSRAM) |
| SI (1) | SI1856090T1 (OSRAM) |
| TN (1) | TNSN07313A1 (OSRAM) |
| WO (1) | WO2006086488A2 (OSRAM) |
| ZA (1) | ZA200706354B (OSRAM) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RS51202B (sr) * | 2004-06-14 | 2010-12-31 | Eli Lilly And Company | Antagonisti receptora za glukagon, dobijanje i terapeutske upotrebe |
| EP2786985B1 (en) | 2007-02-09 | 2018-11-28 | Metabasis Therapeutics, Inc. | Antagonists of the glucagon receptor |
| EP2025674A1 (de) | 2007-08-15 | 2009-02-18 | sanofi-aventis | Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| CN104803891B (zh) | 2008-08-13 | 2017-10-20 | 症变治疗公司 | 胰高血糖素拮抗剂 |
| WO2011107494A1 (de) | 2010-03-03 | 2011-09-09 | Sanofi | Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung |
| EP2582709B1 (de) | 2010-06-18 | 2018-01-24 | Sanofi | Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen |
| US8530413B2 (en) | 2010-06-21 | 2013-09-10 | Sanofi | Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments |
| TW201215388A (en) | 2010-07-05 | 2012-04-16 | Sanofi Sa | (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments |
| TW201221505A (en) | 2010-07-05 | 2012-06-01 | Sanofi Sa | Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament |
| TW201215387A (en) | 2010-07-05 | 2012-04-16 | Sanofi Aventis | Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament |
| JP5694561B2 (ja) | 2010-12-23 | 2015-04-01 | ファイザー・インク | グルカゴン受容体モジュレーター |
| KR101638671B1 (ko) | 2011-02-08 | 2016-07-11 | 화이자 인코포레이티드 | 글루카곤 수용체 조절자 |
| EP2683699B1 (de) | 2011-03-08 | 2015-06-24 | Sanofi | Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
| WO2012120053A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
| EP2683705B1 (de) | 2011-03-08 | 2015-04-22 | Sanofi | Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
| US8901114B2 (en) | 2011-03-08 | 2014-12-02 | Sanofi | Oxathiazine derivatives substituted with carbocycles or heterocycles, method for producing same, drugs containing said compounds, and use thereof |
| WO2012120056A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Tetrasubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
| JP5647379B2 (ja) | 2011-07-22 | 2014-12-24 | ファイザー・インク | キノリニルグルカゴン受容体モジュレーター |
| WO2013037390A1 (en) | 2011-09-12 | 2013-03-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
| EP2567959B1 (en) | 2011-09-12 | 2014-04-16 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
| EP2760862B1 (en) | 2011-09-27 | 2015-10-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
| TW201427658A (zh) | 2012-12-10 | 2014-07-16 | Merck Sharp & Dohme | 藉由投予升糖素受體拮抗劑及膽固醇吸收抑制劑治療糖尿病之方法 |
| US9649294B2 (en) | 2013-11-04 | 2017-05-16 | Merck Sharp & Dohme Corp. | Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use |
| WO2015191900A1 (en) | 2014-06-12 | 2015-12-17 | Ligand Pharmaceuticals, Inc. | Glucagon antagonists |
| EP3350200A4 (en) | 2015-09-18 | 2019-03-27 | Wake Forest University Health Services | ANGIOTENSIN (1 7) ANALOGUE AND ASSOCIATED PROCEDURES |
| US20180289859A1 (en) | 2015-10-05 | 2018-10-11 | Hettwer Holding Aps | Compositions and methods for treatment of bone defects |
| CA2914601A1 (en) * | 2015-12-11 | 2017-06-11 | Wake Forest University Health Sciences | Angiotensin-(1-7) analogs and methods relating thereto |
| CN118236497A (zh) | 2016-08-30 | 2024-06-25 | 瑞泽恩制药公司 | 通过干扰胰高血糖素受体的信号传导治疗重度胰岛素抵抗的方法 |
| EP3529278A1 (en) | 2016-10-20 | 2019-08-28 | Regeneron Pharmaceuticals, Inc. | Methods of lowering blood glucose levels |
| CA3071387A1 (en) | 2017-08-22 | 2019-02-28 | Regeneron Pharmaceuticals, Inc. | Methods of treating urea cycle disorders by interfering with glucagon receptor signaling |
| EP3752249A1 (en) | 2018-02-13 | 2020-12-23 | Ligand Pharmaceuticals, Inc. | Glucagon receptor antagonists |
| EP4285723A3 (en) | 2019-12-20 | 2024-03-27 | Bayer Aktiengesellschaft | Substituted thiophene carboxamides, thiophene carboxylic acids and derivatives thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005511683A (ja) * | 2001-12-03 | 2005-04-28 | ノボ ノルディスク アクティーゼルスカブ | 新規なグルカゴンアンタゴニスト |
| EP1519723A1 (en) * | 2002-06-27 | 2005-04-06 | Novo Nordisk A/S | Novel glucagon antagonists/inverse agonists |
| EP1758859B1 (en) * | 2004-05-28 | 2013-07-17 | Eli Lilly And Company | Glucagon receptor antagonists, preparation and therapeutic uses |
| RS51202B (sr) * | 2004-06-14 | 2010-12-31 | Eli Lilly And Company | Antagonisti receptora za glukagon, dobijanje i terapeutske upotrebe |
-
2006
- 2006-02-09 CA CA2597073A patent/CA2597073C/en not_active Expired - Fee Related
- 2006-02-09 EA EA200701705A patent/EA200701705A1/ru unknown
- 2006-02-09 EP EP06720513A patent/EP1856090B1/en active Active
- 2006-02-09 MX MX2007009661A patent/MX2007009661A/es active IP Right Grant
- 2006-02-09 BR BRPI0607015-9A patent/BRPI0607015A2/pt not_active IP Right Cessation
- 2006-02-09 KR KR1020077018437A patent/KR20070104409A/ko not_active Ceased
- 2006-02-09 SI SI200630534T patent/SI1856090T1/sl unknown
- 2006-02-09 PT PT06720513T patent/PT1856090E/pt unknown
- 2006-02-09 PL PL06720513T patent/PL1856090T3/pl unknown
- 2006-02-09 WO PCT/US2006/004461 patent/WO2006086488A2/en not_active Ceased
- 2006-02-09 AT AT06720513T patent/ATE445609T1/de active
- 2006-02-09 US US11/815,987 patent/US8084489B2/en not_active Expired - Fee Related
- 2006-02-09 CN CN2006800046189A patent/CN101115735B/zh not_active Expired - Fee Related
- 2006-02-09 DK DK06720513T patent/DK1856090T3/da active
- 2006-02-09 ES ES06720513T patent/ES2332470T3/es active Active
- 2006-02-09 AU AU2006213894A patent/AU2006213894B2/en not_active Ceased
- 2006-02-09 JP JP2007555195A patent/JP4988604B2/ja not_active Expired - Fee Related
- 2006-02-09 DE DE602006009773T patent/DE602006009773D1/de active Active
-
2007
- 2007-07-30 IL IL184932A patent/IL184932A0/en unknown
- 2007-07-31 ZA ZA200706354A patent/ZA200706354B/xx unknown
- 2007-08-10 CR CR9304A patent/CR9304A/es not_active Application Discontinuation
- 2007-08-10 TN TNP2007000313A patent/TNSN07313A1/en unknown
- 2007-09-10 NO NO20074567A patent/NO20074567L/no not_active Application Discontinuation
- 2007-09-11 MA MA30221A patent/MA29432B1/fr unknown
-
2009
- 2009-11-12 CY CY20091101192T patent/CY1109624T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008530102A5 (OSRAM) | ||
| JP2008502683A5 (OSRAM) | ||
| AR061667A1 (es) | Arilamidas sustituidas con tetrazol | |
| EA200602058A1 (ru) | Производные адамантилпирролидин-2-она в качестве ингибиторов 11-бета-гидроксистероид-дегидрогеназы | |
| JP2011522789A5 (OSRAM) | ||
| JP2009534468A5 (OSRAM) | ||
| ATE538176T1 (de) | Polymilchsäureharzzusammensetzung | |
| JP2008523069A5 (OSRAM) | ||
| JP2010528089A5 (OSRAM) | ||
| WO2009156861A8 (en) | Substituted pyrimidone derivatives | |
| JP2011154353A5 (OSRAM) | ||
| JP2009515872A5 (OSRAM) | ||
| AR074862A1 (es) | Derivados de heterociclo biciclicos y sus metodos de uso | |
| MY150047A (en) | Method of producing 2'-deoxy-5-azacytidine (decitabine) | |
| JP2012526842A5 (OSRAM) | ||
| WO2009072581A1 (ja) | ラクタム化合物又はその塩及びｐｐａｒ活性化剤 | |
| JP2011517453A5 (OSRAM) | ||
| JP2009538336A5 (OSRAM) | ||
| RU2014128826A (ru) | Дисоли малоновой кислоты и способ получения малонилдигалогенидов | |
| WO2008155668A3 (en) | Heteroarylamide pyrimidone compounds | |
| ZA201002139B (en) | New compounds as adenosine a1 receptor antagonists | |
| JP2012054542A5 (ja) | トリアゾール誘導体および複素環化合物 | |
| JP2006508979A5 (OSRAM) | ||
| EA201071012A1 (ru) | Производные азетидинов, способ их получения и применение их в терапии | |
| JP2003261873A5 (OSRAM) |